Skip to content

Psychological Factors in Cardiac Surgery

Psychological Factors in Cardiac Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04766125
Enrollment
103
Registered
2021-02-23
Start date
2021-02-18
Completion date
2024-06-12
Last updated
2025-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Conditions

Brief summary

The study investigates the effect of adverse event information on adverse event occurrence in patients undergoing elective cardiac surgery in a two-armed, randomized study. One group will receive standard information about adverse events; the second group will receive a standardised elaboration of the standard information. Hypothesis: Elaborated information about adverse events will increase adverse event occurrence, mediated by expectations and anxiety, and moderated by coping style.

Detailed description

If quality assessment indicates that the protocol was not followed adequately, participants will be excluded from data analysis.

Interventions

BEHAVIORALAdverse event information

All patients have access to the standard material about adverse events related to the surgery. One arm will additionally receive elaborated adverse event information from a nurse and a surgeon

Sponsors

Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Adults (18 and older) undergoing elective cardiac surgery at the Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital

Exclusion criteria

* Patients who have previously had cardiac surgery * Cardiac surgery with deep hypothermia (\<32 degrees Celsius) * Acute surgery * Patients with psychiatric or neurological disease who are unable to collaborate with the study protocol * Patients who do not speak/read Danish

Design outcomes

Primary

MeasureTime frame
Number of adverse eventsAssessed on day four

Secondary

MeasureTime frame
Number of adverse eventsAssessed on day 30, 90, and 180
Intensity of experienced adverse eventsAssessed on day four, 30, 90, and 180
Hospital readmissionAssessed on day 180
Occurrence of specific adverse eventsAssessed on day four, 30, 90, and 180

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026